KEGG   PATHWAY: ptao04115
Entry
ptao04115                   Pathway                                
Name
p53 signaling pathway - Phyllopteryx taeniolatus (common seadragon)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
ptao04115  p53 signaling pathway
ptao04115

Organism
Phyllopteryx taeniolatus (common seadragon) [GN:ptao]
Gene
133465156  ccnb1; G2/mitotic-specific cyclin-B1 [KO:K05868]
133465614  cdk21; cyclin-dependent kinase 4 isoform X1 [KO:K02091] [EC:2.7.11.22]
133465942  rprml; reprimo-like protein [KO:K10128]
133466321  [KO:K02159]
133466608  ccndx; cyclin Dx [KO:K10151]
133466745  ei24; etoposide-induced protein 2.4 homolog isoform X1 [KO:K10134]
133467375  ppm1db; protein phosphatase, Mg2+/Mn2+ dependent, 1Db isoform X1 [KO:K10147] [EC:3.1.3.16]
133467490  chek1; serine/threonine-protein kinase Chk1 isoform X1 [KO:K02216] [EC:2.7.11.1]
133468144  [KO:K10808] [EC:1.17.4.1]
133468145  [KO:K10808] [EC:1.17.4.1]
133468178  sesn1; sestrin-1 isoform X1 [KO:K10141]
133468541  thbs1b; thrombospondin-1 [KO:K16857]
133468655  [KO:K04451]
133469083  ptenb; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
133470016  zgc:153993; apoptosis regulator BAX [KO:K02159]
133470915  sesn2; sestrin-2 isoform X1 [KO:K20394]
133470942  rrm2b; ribonucleoside-diphosphate reductase subunit M2 B [KO:K10808] [EC:1.17.4.1]
133471103  cdk6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
133471358  [KO:K04596]
133471632  mdm2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
133471744  apaf1; apoptotic protease-activating factor 1 [KO:K02084]
133471835  [KO:K10151]
133471923  [KO:K06625]
133471976  [KO:K02091] [EC:2.7.11.22]
133472083  igf1; insulin-like growth factor I [KO:K05459]
133472384  serpine1; plasminogen activator inhibitor 1 [KO:K03982]
133472385  tp53; cellular tumor antigen p53 [KO:K04451]
133473318  ccne1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
133474465  [KO:K21770]
133474478  [KO:K06509]
133474479  [KO:K21770]
133474710  rchy1; RING finger and CHY zinc finger domain-containing protein 1 [KO:K10144] [EC:2.3.2.27]
133474766  hdr; hematopoietic death receptor isoform X1 [KO:K04722]
133474889  [KO:K10146]
133475230  gadd45ga; growth arrest and DNA-damage-inducible, gamma a [KO:K04402]
133475665  chek2; serine/threonine-protein kinase Chk2 [KO:K06641] [EC:2.7.11.1]
133475967  casp9; caspase-9 [KO:K04399] [EC:3.4.22.62]
133476343  tsc2; tuberin isoform X1 [KO:K07207]
133476745  casp3a; caspase-3a [KO:K02187] [EC:3.4.22.56]
133477850  gtse1; G2 and S phase-expressed protein 1 isoform X1 [KO:K10129]
133478478  ddb2; DNA damage-binding protein 2 [KO:K10140]
133478502  pidd1; p53-induced death domain-containing protein 1 isoform X1 [KO:K10130]
133478549  znf385a; zinc finger protein 385A isoform X1 [KO:K26543]
133478601  cd82b; CD82 molecule b [KO:K06509]
133478636  siah1; E3 ubiquitin-protein ligase Siah1 [KO:K04506] [EC:2.3.2.27]
133478671  ccnd2a; G1/S-specific cyclin-D2a isoform X1 [KO:K10151]
133478752  [KO:K04726]
133479069  ccne2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
133480183  [KO:K04596]
133480794  igfbp3; insulin-like growth factor-binding protein 3 [KO:K10138]
133480863  gorab; RAB6-interacting golgin [KO:K19748]
133481189  zmat3; zinc finger matrin-type protein 3 isoform X1 [KO:K10137]
133482090  atm; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
133482153  ppp1r13l; relA-associated inhibitor [KO:K27356]
133482793  ccnp; cyclin N-terminal domain-containing protein 2 isoform X1 [KO:K21770]
133482878  tp73; tumor protein p73 [KO:K10148]
133483180  [KO:K10135]
133483272  cdkn1a; cyclin-dependent kinase inhibitor 1 isoform X1 [KO:K06625]
133483314  [KO:K26543]
133483475  mdm4; protein Mdm4 isoform X1 [KO:K10127]
133483625  cdk4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
133483963  cdk2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
133484344  casp3b; caspase-3b [KO:K02187] [EC:3.4.22.56]
133484420  ccng1; cyclin-G1 isoform X1 [KO:K10145]
133484773  sesn4; sestrin-3 isoform X1 [KO:K10141]
133485405  fas; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
133485466  perp; p53 apoptosis effector related to PMP-22 [KO:K10136]
133485477  bcl2l1; bcl-2-like protein 1 isoform X1 [KO:K04570]
133485661  ptena; phosphatase and tensin homolog A isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
133485883  cdk1; cyclin-dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
133486248  [KO:K08738]
133486338  casp10; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
133486340  [KO:K08738]
133486846  igf3; insulin-like growth factor 3 [KO:K05459]
133486866  rprma; protein reprimo A [KO:K10128]
133487727  [KO:K06509]
133487765  siva1; apoptosis regulatory protein Siva isoform X1 [KO:K22744]
133487979  [KO:K16857]
133488156  gadd45bb; growth arrest and DNA-damage-inducible, beta b [KO:K04402]
133488349  atr; serine/threonine-protein kinase ATR isoform X1 [KO:K06640] [EC:2.7.11.1]
133488470  bcl2b; apoptosis regulator Bcl-2 [KO:K02161]
133488498  casp8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
133488798  cop1; E3 ubiquitin-protein ligase COP1 [KO:K10143] [EC:2.3.2.27]
133489038  [KO:K10142] [EC:1.16.1.-]
133489269  gadd45aa; growth arrest and DNA-damage-inducible, alpha, a [KO:K04402]
133489519  [KO:K10138]
133489793  ccng2; cyclin-G2 [KO:K10146]
133490052  [KO:K04402]
133490053  [KO:K04402]
133490291  tnfrsfa; tumor necrosis factor receptor superfamily, member a [KO:K04722]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
ptao04110  Cell cycle
ptao04210  Apoptosis
ptao04218  Cellular senescence
KO pathway
ko04115   

DBGET integrated database retrieval system